PROGRAM CHAIR
Christopher Parker, DO
Rheumatologist
Central Texas Rheumatology Associates
Co-Founder, Gout Support Group of America
West Lake Hills, Texas
FACULTY PRESENTERS
Paul P. Doghramji, MD, FAAFP
Senior Family Practice Physician
Collegeville Family Practice
Medical Director of Health Services
Ursinus College
Collegeville, Pennsylvania
Nissreen Elfadawy, MD, MS, FASN, FAST
Vice Chair, Department of Medicine
Director, Gout and Rare Kidney Disease Program
Clinical Assistant Professor
Case Western Reserve University School of Medicine
Nephrologist | Onconephrologist | Transplant Nephrologist
University Hospitals Geauga Medical Center
Chardon, Ohio
PROGRAM OVERVIEW
This dynamic, panel-style educational program brings together expert perspectives from a rheumatologist, nephrologist, and family practice faculty member to provide a comprehensive, multidisciplinary approach to gout management. Through an interactive interview format, faculty will summarize the health risks and comorbidities associated with gout and discuss practical strategies to reduce long-term morbidity. The panel will review the underlying pathophysiology of gout, including the influence of lifestyle and genetic factors, and translate current guideline recommendations into real-world treatment selection and dosing decisions for long-term disease control. Emphasizing collaborative care, the discussion will also highlight best practices for patient education, appropriate referrals, and coordinated management of comorbidities to optimize outcomes across care settings.
TARGET AUDIENCE
This educational activity is intended for primary care professionals (PCPs), and advanced practice professionals (APPs), including nurse practitioners (NPs) and physician assistants (PAs), nephrologists, and rheumatologists, including rheumatology NPs and PAs, as well as other members of the multidisciplinary team (MDT).
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize the health risks and comorbidities associated with gout and how to reduce morbidity
- Review the pathophysiology of gout as well as the impact of lifestyle and genetic factors
- Describe guideline recommendations for treatment selection and dosing for the long-term management of patients with gout
- Utilize best practices for making referrals, educating patients, and managing comorbidities with a multidisciplinary care approach
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hour.
AAPA CREDIT DESIGNATION STATEMENT – LIVE
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.
This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities that you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Christopher Parker, DO | Consultant: Sobi Speaker’s Bureau: Amgen |
| Paul P. Doghramji, MD | Speaker’s Bureau: Axsome Therapeutics, AstraZeneca, Pfizer, Otsuka, Tonix, Amgen |
| Nissreen Elfadawy, MD | Consultant: Amgen, Novartis, Otsuka |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation & Outcomes Coordinator, for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Bhavadharini Balaji, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Amanda Jenkins, Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: April 30, 2026
EXPIRATION DATE: April 30, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
